60 Degrees Pharmaceuticals (SXTP) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $12225.0.
- 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization rose 18207.2% to $12225.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $12225.0, marking a year-over-year increase of 18207.2%. This contributed to the annual value of $11726.0 for FY2024, which is 4458.94% down from last year.
- As of Q3 2025, 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization stood at $12225.0, which was up 18207.2% from $9236.0 recorded in Q2 2025.
- In the past 5 years, 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $146189.0 in Q3 2023 and a low of $407.0 during Q1 2024
- For the 4-year period, 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization averaged around $43737.7, with its median value being $11726.0 (2024).
- Per our database at Business Quant, 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization tumbled by 9890.83% in 2024 and then soared by 154471.74% in 2025.
- Quarter analysis of 4 years shows 60 Degrees Pharmaceuticals' Accumulated Depreciation & Amortization stood at $126902.0 in 2022, then plummeted by 83.32% to $21162.0 in 2023, then tumbled by 44.59% to $11726.0 in 2024, then grew by 4.26% to $12225.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $12225.0 for Q3 2025, versus $9236.0 for Q2 2025 and $6694.0 for Q1 2025.